Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage 2A Neuroblastoma”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Testing effectiveness (Phase 2)Ended earlyNCT04023331
What this trial is testing

67Cu-SARTATE™ Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High-Risk, Relapsed, Refractory Neuroblastoma

Who this might be right for
NeuroblastomaRelapsed NeuroblastomaRefractory Neuroblastoma
Clarity Pharmaceuticals Ltd 21
Testing effectiveness (Phase 2)UnknownNCT00416559
What this trial is testing

Observation of Young Patients With Localized Neuroblastoma Who Have Undergone Surgery Only

Who this might be right for
Long-term Effects Secondary to Cancer Therapy in ChildrenNeuroblastoma
Children's Cancer and Leukaemia Group 140
Testing effectiveness (Phase 2)Study completedNCT00001509
What this trial is testing

A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor

Who this might be right for
NephroblastomaNeuroblastoma
National Cancer Institute (NCI) 60
Not applicableActive Not RecruitingNCT03057626
What this trial is testing

Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma

Who this might be right for
Recurrent NeuroblastomaStage 2A NeuroblastomaStage 2B Neuroblastoma+3 more
Children's Oncology Group 376
Early research (Phase 1)Study completedNCT01798004
What this trial is testing

Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

Who this might be right for
GanglioneuroblastomaStage 1 NeuroblastomaStage 2 Neuroblastoma+5 more
Children's Oncology Group 150
Testing effectiveness (Phase 2)UnknownNCT00003122
What this trial is testing

Surgery in Treating Patients With Neuroblastoma

Who this might be right for
Neuroblastoma
Societe Internationale d'Oncologie Pediatrique 210
Early research (Phase 1)Study completedNCT00509691
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Who this might be right for
Cancer
University of Louisville 20
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT00659984
What this trial is testing

N2007-01: Ultratrace™ Iobenguane I 131 in Patients With Relapsed/Refractory High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
Molecular Insight Pharmaceuticals, Inc. 15